Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Nicolas Casadei
Research Interests
Explore related searches
Articles (8)
Year:
2025
Background Most Parkinson's disease (PD) loci have shown low prevalence in the Indian population, highlighting the need for further research. Objective The aim of this study was to characterize a novel phosphatase tensin homolog‐induced serine/threonine kinase 1 ( PINK1 ) mutation causing PD in an Indian family. Methods Exome sequencing of a well‐characterized Indian family with PD. A novel PINK1 mutation was studied by in silico modeling using AlphaFold2, expression of mutant PINK1 in human cells depleted of functional endogenous PINK1, followed by quantitative image analysis and biochemical assessment. Results We identified a homozygous chr1:20648535–20648535 T>C on GRCh38 (p.F385S) mutation in exon 6 of PINK1 , which was absent in 1029 genomes from India and in other known databases. PINK1 F385S lies within the highly conserved Deutsche Forschungsgemeinschaft (DFG) motif, destabilizes its active state, and impairs phosphorylation of ubiquitin at serine 65 and proper engagement of parkin upon mitochondrial depolarization. Conclusions We characterized a novel nonconservative mutation in the DFG motif of PINK1 , which causes loss of its ubiquitin kinase activity and inhibition of mitophagy. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Collaborators (9)
Annalisa Nobili
University Campus Bio-Medico
Julia Fitzgerald
Research Group Leader
Hertie Institute for clinical brain research
Manu Sharma
-
Ada Ledonne
-
Matthias Vorgerd
-
Meltem Avci-Adali
Research Director
University Hospital Tübingen
Rudi Balling
Senior Professor
University of Bonn
Rebecca Buchert
Research Group Leader
Universitätsklinikum Tübingen
Thomas Gasser
Group Leader
Deutsches Zentrum für Neurodegenerative Erkrankungen
Make your next move.
Prepare your application
Review drafts before you send them.